MicroRNAs: Key players in carcinogenesis and novel therapeutic targets

被引：108
|
作者：
Mirnezami, A. H. F. [1 ]
Pickard, K. [2 ]
Zhang, L. [2 ]
Primrose, J. N. [1 ]
Packham, G. [2 ]
机构：
[1] Southampton Gen Hosp, Level F Ctr Block, Univ Surg Unit, Southampton SO16 6YD, Hants, England
[2] Univ Southampton, Canc Sci Div, Southampton, Hants, England
来源：
EJSO | 2009年 / 35卷 / 04期
关键词：
MicroRNA; Molecular profiling; Cancer; Clinical utility; HUMAN LUNG CANCERS; GENE-EXPRESSION; BREAST-CANCER; SMALL RNAS; ANTISENSE OLIGONUCLEOTIDES; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; IN-VIVO; PROSTATE; GROWTH;
D O I：
10.1016/j.ejso.2008.06.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MicroRNAs (miRNAs) represent a recently uncovered class of small and endogenous non-coding RNAs. MiRNA function is critical to normal cellular processes such as differentiation and apoptosis, and recent studies have demonstrated that deregulated miRNA expression contributes to the malignant phenotype. The purpose of this review is to summarise these findings in relation to the most common human malignancies, and to analyse the clinical and therapeutic opportunities they provide. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：339 / 347
页数：9
相关论文
共 50 条
  • [31] MicroRNAs as therapeutic targets in atherosclerosis
    Loyer, Xavier
    Mallat, Ziad
    Boulanger, Chantal M.
    Tedgui, Alain
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (04) : 489 - 496
  • [32] MicroRNAs as therapeutic targets in chemoresistance
    Garofalo, Michela
    Croce, Carlo M.
    DRUG RESISTANCE UPDATES, 2013, 16 (3-5) : 47 - 59
  • [33] MicroRNAs, Key Regulators in Glioma Progression as Potential Therapeutic Targets for Chinese Medicine
    Fan, Huali
    Xie, Xiaofang
    Kuang, Xi
    Du, Junrong
    Peng, Fu
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2022, 50 (07): : 1799 - 1825
  • [34] MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis (vol 46, pg 918, 2013)
    Vannini, Ivan
    Fanini, Francesca
    Fabbri, Muller
    CLINICAL BIOCHEMISTRY, 2019, 68 : 58 - 58
  • [35] MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis (vol 46, pg 918, 2013)
    Vannini, Ivan
    Fanini, Francesca
    Fabbri, Muller
    CLINICAL BIOCHEMISTRY, 2019, 63 : 162 - 162
  • [36] Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis
    Yu, Zhun
    Yin, JinZhu
    Tang, ZhiTong
    Hu, Ting
    Wang, ZhuoEr
    Chen, Ying
    Liu, Tianjia
    Zhang, Wei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [37] Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets
    Spear, Estelle T.
    Mawe, Gary M.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2019, 317 (06): : G853 - G861
  • [38] Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
    Ramji, Dipak P.
    Davies, Thomas S.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (06) : 673 - 685
  • [39] MicroRNAs as Therapeutic Targets in Colitis and Colitis-Associated Cancer: Tiny Players With a Giant Impact
    Goel, Ajay
    GASTROENTEROLOGY, 2015, 149 (04) : 859 - 861
  • [40] Secreted microRNAs from prostate cancer cells: Novel therapeutic targets
    Farina, Nicholas H.
    Callahan, Cody J.
    Tye, Coralee E.
    Boyd, Joseph R.
    Stein, Gary S.
    Stein, Janet L.
    Lian, Jane B.
    CANCER RESEARCH, 2016, 76
12345